World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization. Available at: Accessed January 13, 2014
World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization. Available at: http: //www.who.int/hiv/pub/ guidelines/arv2013/download/en/. Accessed January 13, 2014.
2
84923656159
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Bethesda, Maryland: National Institutes of Health. Available at: . Accessed January 13, 2014
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Bethesda, Maryland: National Institutes of Health. Available at: http: // aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf. Accessed January 13, 2014.
3
79959951684
Antiretroviral drugs for preventing mother-to-child transmission of hiv: A review of potential effects on hiv-exposed but uninfected children
Heidari S, Mofenson L, Cotton MF, et al. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011; 57: 290-296.
Screening for hiv in pregnant women: Systematic review to update the 2005 u.s
Chou R, Cantor AG, Zakher B, et al. Screening for HIV in pregnant women: systematic review to update the 2005 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2012; 157: 719-728.
Increased risk of preterm delivery among hiv-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based haart during pregnancy
Powis KM, Kitch D, Ogwu A, et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011; 204: 506-514.
Pregnancy outcomes in women exposed to efavirenz and nevirapine: An appraisal of the iedea west africa and anrs databases, abidjan, cote d'ivoire
Ekouevi DK, Coffie PA, Ouattara E, et al. Pregnancy outcomes in women exposed to Efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS databases, Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2011; 56: 183-187.
Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 July 2013. Wilmington, NC: Registry Coordinating Center. p10; 17-20; 27-28; 29-30; 49-50. Issued 12-1-2013
Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 July 2013. Wilmington, NC: Registry Coordinating Center. p10; 17-20; 27-28; 29-30; 49-50. Issued 12-1-2013. Available at www.apregistry.com.
9
38549153893
Metropolitan atlanta congenital defects program 40th anniversary edition surveillance report: Reporting birth defects surveillance data 1968-2003
Correa A, Cragan J, Kucik J, et al. Metropolitan Atlanta Congenital Defects Program 40th Anniversary Edition Surveillance Report: Reporting Birth Defects Surveillance Data 1968-2003. Birth Defects Research (Part A) Erratum: 2008; 82: 41-62.
Estimated number of infants born to hiv-infected women in the united states and five dependent areas, 2006
Whitmore SK, Zhang X, Taylor AW, et al. Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006. J Acquire Immune Defic Syndr. 2011; 57: 218-222.
Confidence intervals for binomial proportions with applications to product safety signaling in drug exposure registries
July 30-August 4,; Miami, Florida.
Schuette PH, Rochester GG. Confidence Intervals for Binomial Proportions with Applications to Product Safety Signaling in Drug Exposure Registries. Paper presented at: Joint Statistical Meetings; July 30-August 4, 2011; Miami, Florida.
Power and sample size for safety registries: New methods using confidence intervals and sawtooth power curves
June 12-15,; Nashville, Tennessee.
Schuette PH, Jackson MT, Rochester GG. Power and Sample Size for Safety Registries: New Methods Using Confidence Intervals and Sawtooth Power Curves. Paper presented at: useR! The 8th International R User Conference; June 12-15, 2012; Nashville, Tennessee
